[{"quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124-001", "question": "A 27-year-old G1P0 at 9 weeks' gestation presents with intractable nausea and vomiting, 7-kg weight loss, new-onset jaundice, and confusion over 3 days. She has no prior liver disease or alcohol use. Vitals: T 37.2°C, HR 122, BP 100/62, RR 18, SpO2 98% RA. Exam: scleral icterus, moderate right upper quadrant tenderness without rebound, asterixis. Labs: Na 132, K 3.1, bicarbonate 19, creatinine 1.2 mg/dL (baseline 0.6), AST 545 U/L, ALT 510 U/L, ALP 225 U/L, total bilirubin 12.4 mg/dL (direct 8.1), INR 2.6, ammonia 102 µmol/L, β-hCG markedly elevated for gestational age, thyroid studies: TSH low, free T4 and T3 mildly elevated. Abdominal ultrasound: single live intrauterine pregnancy, normal hepatic and portal vasculature, no biliary dilation, mild fatty liver change. Viral hepatitis serologies and autoimmune markers are pending. She is receiving IV fluids and antiemetics but continues to deteriorate neurologically. Which of the following is the most appropriate immediate next management step?", "options": ["Administer high-dose IV methylprednisolone and defer pregnancy decisions until serologies return", "Urgently proceed with uterine evacuation and initiate N-acetylcysteine infusion", "Start high-dose IV thiamine and parenteral nutrition while continuing pregnancy", "List for emergent liver transplantation without altering pregnancy status", "Administer propylthiouracil and beta-blockers to treat probable gestational thyrotoxicosis and reassess"], "answer": "B", "answer_index": 1, "explanation": "This presentation is most consistent with hyperemesis gravidarum-associated acute liver failure with encephalopathy and coagulopathy; maternal survival takes precedence, and rapid uterine evacuation plus N-acetylcysteine offers the best chance to reverse fulminant hepatic injury. Steroids (A) address autoimmune hepatitis, which is unconfirmed and too slow. Thiamine and nutrition (C) are supportive but insufficient in fulminant failure with encephalopathy. Immediate transplantation listing (D) may be needed but should follow rapid removal of the precipitating factor. Treating mild gestational thyrotoxicosis alone (E) will not address the primary life-threatening hepatic process.", "generator_model": "gpt-5.1-2025-11-13", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity: U (Underspecified). The vignette presents fulminant hepatic failure at 9 weeks gestation with encephalopathy and markedly elevated β-hCG, yet ultrasound reports a 'single live intrauterine pregnancy'—contradictory findings that prevent definitive diagnosis. Hyperemesis gravidarum does not cause ALF this early; possibilities include unconfirmed molar pregnancy or atypical AFLP. The keyed answer B recommends urgent uterine evacuation plus N-acetylcysteine as the 'best chance to reverse' injury, which is not evidence-based or standard of care for early pregnancy ALF. Proper management requires N-acetylcysteine (appropriate) with maternal stabilization and definitive diagnosis before termination. Options C (thiamine for possible Wernicke's encephalopathy) and D (transplant evaluation) are also defensible, making the best answer non-unique. Medical accuracy is poor due to endorsing a potentially harmful, non-standard intervention. Minimal fix: Clarify diagnosis (e.g., confirmed complete mole) or revise key to 'N-acetylcysteine + intensive support with multidisciplinary obstetric consultation' before considering evacuation.\",\n\"medical_accuracy_score\": 2,\n\"logical_validity\": false,\n\"logical_false_reason\": \"U\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: U (Underspecified). The vignette presents fulminant hepatic failure at 9 weeks gestation with encephalopathy and markedly elevated β-hCG, yet ultrasound reports a 'single live intrauterine pregnancy'—contradictory findings that prevent definitive diagnosis. Hyperemesis gravidarum does not cause ALF this early; possibilities include unconfirmed molar pregnancy or atypical AFLP. The keyed answer B recommends urgent uterine evacuation plus N-acetylcysteine as the 'best chance to reverse' injury, which is not evidence-based or standard of care for early pregnancy ALF. Proper management requires N-acetylcysteine (appropriate) with maternal stabilization and definitive diagnosis before termination. Options C (thiamine for possible Wernicke's encephalopathy) and D (transplant evaluation) are also defensible, making the best answer non-unique. Medical accuracy is poor due to endorsing a potentially harmful, non-standard intervention. Minimal fix: Clarify diagnosis (e.g., confirmed complete mole) or revise key to 'N-acetylcysteine + intensive support with multidisciplinary obstetric consultation' before considering evacuation.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "U", "verdict": "FAIL", "fail_reason": "U"}, "judge_verdict": "FAIL", "judge_fail_reason": "U", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124-002", "question": "A 63-year-old man with long-standing hypertension and ischemic cardiomyopathy (EF 30%) presents with acute right hemiplegia and aphasia 45 minutes after symptom onset. NIHSS is 18. Noncontrast CT head shows no hemorrhage. CT angiography shows left M1 occlusion with favorable collaterals; CT perfusion suggests a large salvageable penumbra. ECG shows sinus rhythm with frequent PVCs. High-sensitivity troponin is mildly elevated and flat on serial testing. You plan IV thrombolysis and urgent mechanical thrombectomy. Which of the following additional acute management steps is most appropriate?", "options": ["Initiate IV unfractionated heparin infusion before mechanical thrombectomy due to high cardioembolic risk", "Administer IV labetalol to reduce blood pressure to <140/90 mm Hg prior to thrombolysis", "Start high-dose statin and delay any antiplatelet therapy until 24 hours after thrombolysis", "Begin dual antiplatelet therapy with aspirin and clopidogrel immediately after thrombolysis", "Place an intra-aortic balloon pump preemptively to support cerebral perfusion during thrombectomy"], "answer": "C", "answer_index": 2, "explanation": "The correct step is to start high-intensity statin immediately and delay antiplatelets until 24 hours after thrombolysis and repeat imaging, per acute ischemic stroke guidelines. Heparin before thrombectomy (A) increases hemorrhagic risk with no proven benefit. Lowering BP below 140/90 (B) before tPA is too aggressive and can worsen cerebral perfusion; only treat if >185/110 to that threshold. Dual antiplatelets immediately after tPA (D) markedly increases hemorrhage risk. Intra-aortic balloon pump (E) has no role in this setting and carries procedural risk.", "generator_model": "gpt-5.1-2025-11-13", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity: V (Valid). This item presents a clear, guideline-concordant acute ischemic stroke scenario. Key discriminating features: 45-minute symptom onset, severe deficit (NIHSS 18), left M1 occlusion with favorable collaterals/large penumbra, planned IV thrombolysis plus mechanical thrombectomy. The question seeks the most appropriate additional acute management. Option C—starting high-intensity statin immediately while delaying antiplatelet therapy for 24 hours post-thrombolysis—is uniquely correct and directly supported by AHA/ASA guidelines (Class I for early statin, Class III: Harm for early antiplatelets). The alternatives are unequivocally incorrect: A (pre-thrombectomy heparin) and D (immediate DAPT) increase hemorrhagic conversion risk without evidence of benefit; B (target BP <140/90) is overly aggressive and risks worsening penumbral perfusion (guidelines only recommend treating BP >185/110 mmHg pre-thrombolysis); E (IABP) has no role in stroke care and adds procedural risk. The low EF and PVCs do not alter these fundamental stroke management principles. No internal contradictions or underspecification exists. Medical accuracy is excellent and current. Minimal fix: None required.\",\n\"medical_accuracy_score\": 5,\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). This item presents a clear, guideline-concordant acute ischemic stroke scenario. Key discriminating features: 45-minute symptom onset, severe deficit (NIHSS 18), left M1 occlusion with favorable collaterals/large penumbra, planned IV thrombolysis plus mechanical thrombectomy. The question seeks the most appropriate additional acute management. Option C—starting high-intensity statin immediately while delaying antiplatelet therapy for 24 hours post-thrombolysis—is uniquely correct and directly supported by AHA/ASA guidelines (Class I for early statin, Class III: Harm for early antiplatelets). The alternatives are unequivocally incorrect: A (pre-thrombectomy heparin) and D (immediate DAPT) increase hemorrhagic conversion risk without evidence of benefit; B (target BP <140/90) is overly aggressive and risks worsening penumbral perfusion (guidelines only recommend treating BP >185/110 mmHg pre-thrombolysis); E (IABP) has no role in stroke care and adds procedural risk. The low EF and PVCs do not alter these fundamental stroke management principles. No internal contradictions or underspecification exists. Medical accuracy is excellent and current. Minimal fix: None required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124-003", "question": "A 34-year-old woman with SLE (malar rash, arthritis, class III lupus nephritis on biopsy) on mycophenolate and low-dose prednisone presents with 3 months of progressive exertional dyspnea and dry cough. She has no smoking history. Vitals: HR 96, BP 112/70, RR 18, SpO2 94% RA. Exam: fine bibasilar crackles, no peripheral edema. Labs: creatinine 1.0 mg/dL, ANA 1:640 homogeneous, anti-dsDNA mildly elevated, complements low, ESR 18 mm/hr, CRP 2 mg/L. PFTs: FVC 65% predicted, FEV1/FVC 0.82, DLCO 40% predicted. HRCT: diffuse ground-glass opacities with scattered areas of consolidation and traction bronchiectasis, predominantly in lower lobes, no honeycombing. BAL: lymphocytic predominance, cultures negative. Echocardiogram: normal LV function, PASP 30 mm Hg. Which of the following is the most appropriate next step in management?", "options": ["Escalate mycophenolate dose and add high-dose oral prednisone without further diagnostics", "Switch mycophenolate to cyclophosphamide and simultaneously list for lung transplantation", "Perform surgical lung biopsy to distinguish organizing pneumonia from NSIP", "Add rituximab while continuing mycophenolate at the same dose", "Initiate nintedanib in addition to current immunosuppression for progressive fibrosing ILD"], "answer": "E", "answer_index": 4, "explanation": "This is SLE-associated progressive fibrosing interstitial lung disease with traction bronchiectasis and physiologic restriction despite immunosuppression; nintedanib has evidence for slowing decline in progressive fibrosing ILDs, including CTD-ILD. Blind escalation of steroids/mycophenolate (A) risks toxicity without clear additional benefit. Routine upfront lung transplant listing (B) is premature. Lung biopsy (C) is high risk and unlikely to alter management given established CTD-ILD pattern. Rituximab (D) can be considered, but antifibrotic therapy specifically targets the progressive fibrosing phenotype and is strongly indicated here.", "generator_model": "gpt-5.1-2025-11-13", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity: V (Valid). This item successfully tests management of SLE-associated progressive fibrosing ILD. Key stem clues establishing a fibrotic phenotype despite immunosuppression include: 3 months of progressive exertional dyspnea, traction bronchiectasis on HRCT without honeycombing, severely reduced DLCO (40%), and ongoing immunosuppression with mycophenolate and prednisone. The lymphocytic BAL and ground-glass opacities suggest residual inflammation, but the traction bronchiectasis signals fibrotic remodeling that defines the progressive fibrosing phenotype. The keyed answer E (nintedanib) is uniquely best: it directly targets fibrotic progression with evidence from INBUILD and is strongly recommended by 2022 ATS/ERS guidelines for PF-ILD, whereas option A risks steroid toxicity without clear benefit in fibrosis, B is premature given preserved SpO2 and lack of severe PH, C is unnecessary when CTD-ILD pattern is established, and D addresses inflammation but not the dominant fibrotic process. No internal contradictions or critical missing details prevent selection of a single best answer. Medical accuracy is current, guideline-concordant, and board-relevant. Minimal fix: None required.\",\n\"medical_accuracy_score\": 5,\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). This item successfully tests management of SLE-associated progressive fibrosing ILD. Key stem clues establishing a fibrotic phenotype despite immunosuppression include: 3 months of progressive exertional dyspnea, traction bronchiectasis on HRCT without honeycombing, severely reduced DLCO (40%), and ongoing immunosuppression with mycophenolate and prednisone. The lymphocytic BAL and ground-glass opacities suggest residual inflammation, but the traction bronchiectasis signals fibrotic remodeling that defines the progressive fibrosing phenotype. The keyed answer E (nintedanib) is uniquely best: it directly targets fibrotic progression with evidence from INBUILD and is strongly recommended by 2022 ATS/ERS guidelines for PF-ILD, whereas option A risks steroid toxicity without clear benefit in fibrosis, B is premature given preserved SpO2 and lack of severe PH, C is unnecessary when CTD-ILD pattern is established, and D addresses inflammation but not the dominant fibrotic process. No internal contradictions or critical missing details prevent selection of a single best answer. Medical accuracy is current, guideline-concordant, and board-relevant. Minimal fix: None required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124-004", "question": "A 51-year-old woman with poorly controlled type 2 diabetes and prior pelvic radiation for cervical cancer presents with 5 days of fever, worsening lower abdominal pain, and foul vaginal discharge. She is hypotensive and tachycardic. Exam: diffuse lower abdominal tenderness with guarding, necrotic friable tissue at the posterior vaginal fornix with gas bubbles and crepitus extending toward the rectovaginal septum. Labs: WBC 19,000/µL, lactate 4.5 mmol/L, creatinine 2.1 mg/dL. CT abdomen/pelvis with contrast: extensive gas in the pelvis tracking along fascial planes into the perineum, no discrete drainable collection, suspected uterine and vaginal wall necrosis. Blood cultures are drawn, and broad-spectrum IV antibiotics and aggressive fluids are started. Which is the most appropriate next step?", "options": ["Urgent total abdominal hysterectomy with wide radical debridement of necrotic pelvic and perineal tissue", "Percutaneous CT-guided drainage of gas-containing pelvic spaces plus continued maximal antibiotics", "Hyperbaric oxygen therapy as a temporizing measure before any surgical intervention", "Emergent exploratory laparotomy limited to diagnostic assessment and peritoneal lavage", "Conservative management with antibiotics and close ICU monitoring to avoid worsening radiation injury"], "answer": "A", "answer_index": 0, "explanation": "The clinical picture is necrotizing pelvic soft tissue infection (type I Fournier-like process) involving uterus and vagina in a radiated field, requiring immediate radical surgical debridement including hysterectomy. Percutaneous drainage (B) is inadequate for necrotizing fasciitis. Hyperbaric oxygen (C) may be adjunctive but never replaces urgent debridement. Exploratory laparotomy without aggressive debridement (D) fails to control source. Conservative management (E) carries an almost universally fatal risk in necrotizing infections.", "generator_model": "gpt-5.1-2025-11-13", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). The vignette presents a classic necrotizing pelvic soft-tissue infection (Fournier-like gangrene) in a high-risk host (diabetes, radiation). Key discriminating findings include: crepitus/gas on exam and CT tracking along fascial planes, necrotic vaginal fornix tissue, systemic toxicity (hypotension, tachycardia, lactate 4.5), leukocytosis, and CT showing no discrete collection but suspected uterine/vaginal necrosis. These findings mandate immediate radical surgical debridement. Option A is uniquely defensible: total abdominal hysterectomy with wide debridement directly addresses the necrotic uterus/vagina and fulminant infection. Option B fails because percutaneous drainage is ineffective without a discrete collection and for necrotizing fasciitis. Option C is incorrect as hyperbaric oxygen is adjunctive, not a temporizing alternative to surgery. Option D is inadequate because limited laparotomy without debridement cannot control the source. Option E is contraindicated and fatal. The keyed answer A aligns perfectly with standard-of-care principles for necrotizing fasciitis. No medical inaccuracies or logical flaws are present. Minimal fix: none required; item is board-ready.\",\"medical_accuracy_score\":5,\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). The vignette presents a classic necrotizing pelvic soft-tissue infection (Fournier-like gangrene) in a high-risk host (diabetes, radiation). Key discriminating findings include: crepitus/gas on exam and CT tracking along fascial planes, necrotic vaginal fornix tissue, systemic toxicity (hypotension, tachycardia, lactate 4.5), leukocytosis, and CT showing no discrete collection but suspected uterine/vaginal necrosis. These findings mandate immediate radical surgical debridement. Option A is uniquely defensible: total abdominal hysterectomy with wide debridement directly addresses the necrotic uterus/vagina and fulminant infection. Option B fails because percutaneous drainage is ineffective without a discrete collection and for necrotizing fasciitis. Option C is incorrect as hyperbaric oxygen is adjunctive, not a temporizing alternative to surgery. Option D is inadequate because limited laparotomy without debridement cannot control the source. Option E is contraindicated and fatal. The keyed answer A aligns perfectly with standard-of-care principles for necrotizing fasciitis. No medical inaccuracies or logical flaws are present. Minimal fix: none required; item is board-ready.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124-005", "question": "A 76-year-old man with permanent atrial fibrillation on apixaban, CKD stage 3b, and prior TIA undergoes TAVR for symptomatic severe aortic stenosis. Preprocedure echo: EF 55%, no intracardiac thrombus, moderate MAC, mild-moderate MR. Postprocedure, he develops acute severe dyspnea and hypotension 2 hours later. Echo: hyperdynamic LV with near-complete mid-cavity obliteration in systole, peak LVOT gradient 80 mm Hg, systolic anterior motion (SAM) of the mitral valve, severe MR, intact TAVR function. Which of the following is the most appropriate immediate management?", "options": ["Start high-dose IV furosemide and nitroprusside to rapidly reduce preload and afterload", "Administer aggressive IV crystalloids and start a phenylephrine infusion while reducing inotropes", "Urgently return to the cath lab for balloon post-dilatation of the TAVR prosthesis", "Begin IV milrinone infusion to augment contractility and improve forward flow", "Perform emergent surgical myectomy with mitral valve repair"], "answer": "B", "answer_index": 1, "explanation": "This is dynamic LVOT obstruction with SAM and severe MR precipitated by TAVR and low preload; management mirrors hypertrophic obstructive physiology-volume expansion and pure alpha-agonist (phenylephrine) to increase afterload while avoiding inotropes. Diuresis and vasodilators (A) and inotropes (D) worsen obstruction. Post-dilatation of the valve (C) is not indicated as prosthetic function is normal. Emergent surgery (E) is reserved for refractory cases after optimal medical hemodynamic management has failed.", "generator_model": "gpt-5.1-2025-11-13", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity: V. This is a well-constructed item describing dynamic LVOT obstruction with SAM and severe MR occurring 2 hours after TAVR. The vignette provides all necessary discriminating features: hyperdynamic LV with near-complete mid-cavity obliteration, peak LVOT gradient 80 mm Hg, SAM, severe MR, and intact TAVR function. The keyed answer B (aggressive IV crystalloids + phenylephrine while reducing inotropes) is the single best immediate management, directly addressing the underlying pathophysiology by increasing preload and afterload while avoiding inotropic stimulation that would worsen obstruction. Options A (diuretics/vasodilators) and D (milrinone) are contraindicated as they would exacerbate the gradient. Option C is inappropriate given normal prosthetic function. Option E is reserved for refractory cases after optimal medical management. No internal contradictions or missing critical details are present. Medical accuracy is excellent: the management strategy mirrors established principles for hypertrophic obstructive physiology and contemporary guidelines for post-TAVR complications. The explanation correctly identifies why other options are harmful. No revisions needed.\",\n\"medical_accuracy_score\": 5,\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. This is a well-constructed item describing dynamic LVOT obstruction with SAM and severe MR occurring 2 hours after TAVR. The vignette provides all necessary discriminating features: hyperdynamic LV with near-complete mid-cavity obliteration, peak LVOT gradient 80 mm Hg, SAM, severe MR, and intact TAVR function. The keyed answer B (aggressive IV crystalloids + phenylephrine while reducing inotropes) is the single best immediate management, directly addressing the underlying pathophysiology by increasing preload and afterload while avoiding inotropic stimulation that would worsen obstruction. Options A (diuretics/vasodilators) and D (milrinone) are contraindicated as they would exacerbate the gradient. Option C is inappropriate given normal prosthetic function. Option E is reserved for refractory cases after optimal medical management. No internal contradictions or missing critical details are present. Medical accuracy is excellent: the management strategy mirrors established principles for hypertrophic obstructive physiology and contemporary guidelines for post-TAVR complications. The explanation correctly identifies why other options are harmful. No revisions needed.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124-006", "question": "A 42-year-old man who injects drugs presents with 10 days of fever, severe back pain, and new right leg weakness. Vitals: T 38.8°C, HR 108, BP 122/74. Exam: midline lumbar tenderness, right leg 3/5 strength with hyperreflexia, left leg 5/5, intact sensation, no bowel/bladder symptoms. Labs: WBC 15,000/µL, ESR 96 mm/hr, CRP 120 mg/L. Blood cultures: MRSA in 2/2 sets. MRI lumbar spine with contrast: dorsal epidural collection L2-L4 with significant canal compromise and enhancement consistent with epidural abscess, plus adjacent vertebral osteomyelitis; no discrete psoas abscess. He is started on IV vancomycin. Neurosurgery feels surgery is high risk due to severe cardiomyopathy (EF 20%) and active drug use, recommending medical therapy unless deterioration. What is the most appropriate next step?", "options": ["Continue IV vancomycin alone with close neurologic monitoring for at least 6 weeks", "Add rifampin to vancomycin to enhance penetration into epidural space and bone", "Perform urgent surgical decompression and drainage despite high perioperative risk", "Switch to daptomycin plus ceftaroline to provide broader MRSA coverage", "Place percutaneous CT-guided drain into the epidural collection to avoid open surgery"], "answer": "C", "answer_index": 2, "explanation": "He has spinal epidural abscess with evolving motor deficit and significant canal compromise; urgent surgical decompression and drainage is indicated despite elevated operative risk, as delay risks permanent paralysis. Medical therapy alone (A, B, D) is inadequate once neurologic deficits are present. Percutaneous drainage (E) is not appropriate for epidural abscess causing cord compression, as it rarely achieves effective decompression or safe access to the epidural space.", "generator_model": "gpt-5.1-2025-11-13", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity: M (Multiple answers defensible). The stem presents a spinal epidural abscess with motor deficit and canal compromise—standard indications for urgent surgical decompression (Option C). However, it explicitly states neurosurgery recommends medical therapy due to severe cardiomyopathy (EF 20%) and active drug use, making Option A equally defensible as following specialist guidance in an extremely high-risk patient. The question does not clarify whether deficits are stable or progressive, nor quantify surgical risk beyond EF, leaving both surgical and medical pathways reasonable. While the key aligns with guideline-based teaching that neurologic deficit mandates surgery, the explicit specialist recommendation creates a legitimate clinical dilemma where medical management is a viable alternative, violating the single-best-answer requirement. Medical accuracy is sound regarding SEA pathophysiology and microbiology, but the clinical decision-making is oversimplified. Minimal fix: Reframe the neurosurgery statement to indicate they concur surgery is indicated but note the risks, or specify rapidly progressive deficits making surgery unequivocally necessary.\",\n\"medical_accuracy_score\": 4,\n\"logical_validity\": false,\n\"logical_false_reason\": \"M\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: M (Multiple answers defensible). The stem presents a spinal epidural abscess with motor deficit and canal compromise—standard indications for urgent surgical decompression (Option C). However, it explicitly states neurosurgery recommends medical therapy due to severe cardiomyopathy (EF 20%) and active drug use, making Option A equally defensible as following specialist guidance in an extremely high-risk patient. The question does not clarify whether deficits are stable or progressive, nor quantify surgical risk beyond EF, leaving both surgical and medical pathways reasonable. While the key aligns with guideline-based teaching that neurologic deficit mandates surgery, the explicit specialist recommendation creates a legitimate clinical dilemma where medical management is a viable alternative, violating the single-best-answer requirement. Medical accuracy is sound regarding SEA pathophysiology and microbiology, but the clinical decision-making is oversimplified. Minimal fix: Reframe the neurosurgery statement to indicate they concur surgery is indicated but note the risks, or specify rapidly progressive deficits making surgery unequivocally necessary.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124-007", "question": "A 31-year-old woman presents with severe headaches, transient visual obscurations, and pulsatile tinnitus 6 months postpartum. She has gained 20 kg during and after pregnancy. BMI is 38 kg/m². Exam: bilateral papilledema, full strength, no focal deficits. MRI brain with and without contrast is normal. MRV shows smooth tapering and non-visualization of the terminal right transverse sinus with small caliber sigmoid sinus and jugular bulb; the left transverse sinus is dominant and widely patent. Lumbar puncture: opening pressure 34 cm H₂O, normal CSF studies. She is started on acetazolamide and advised weight loss but continues to have progressive visual field loss on serial perimetry over 8 weeks. What is the most appropriate next step in management?", "options": ["Place a ventriculoperitoneal shunt to lower intracranial pressure", "Perform right transverse sinus stenting across the narrowed segment", "Initiate high-dose oral topiramate instead of acetazolamide", "Perform optic nerve sheath fenestration to protect vision", "Start therapeutic anticoagulation for presumed chronic venous sinus thrombosis"], "answer": "D", "answer_index": 3, "explanation": "The patient has idiopathic intracranial hypertension with rapidly progressive visual loss despite maximal medical therapy; optic nerve sheath fenestration is the preferred intervention to promptly protect vision. VP shunting (A) is an option but has higher long-term failure and complication rates and is usually considered after or when ONSF is not feasible. Transverse sinus stenting (B) is usually reserved for documented significant pressure gradients and bilateral or dominant-sided stenosis; here the right sinus is small and nondominant. Topiramate (C) is an adjunct but insufficient alone given progressive visual decline. Anticoagulation (E) is not indicated without imaging evidence of thrombosis.", "generator_model": "gpt-5.1-2025-11-13", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity: V (Valid). Verdict: Correct best. Key stem clues: 31-year-old postpartum obese woman (BMI 38) with papilledema, elevated LP opening pressure (34 cm H₂O), normal MRI, MRV showing non-dominant right transverse sinus stenosis, and progressive visual field loss despite acetazolamide and weight loss counseling. These findings define medically refractory IIH with vision threat. Main logical issue: None. The item presents a single best answer. ONSF (D) is the most vision-specific intervention. Alternative analysis: VP shunt (A) is also a standard option for refractory IIH, but the question's emphasis on progressive *visual* loss and the provided rationale correctly position ONSF as the preferred immediate step for vision protection. Transverse sinus stenting (B) is inappropriate for a non-dominant stenosis without a pressure gradient. Topiramate (C) is insufficient as a medical escalation in the face of progressive vision loss. Anticoagulation (E) is not indicated without thrombosis. Medical accuracy: The keyed answer aligns with mainstream neuro-ophthalmology practice where ONSF is favored for urgent vision protection. The rationale is slightly simplified regarding VP shunt timing but is board-appropriate. Score: 4. Minimal fix: None required; item is well-constructed and discriminates appropriately.\",\n\"medical_accuracy_score\": 4,\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best. Key stem clues: 31-year-old postpartum obese woman (BMI 38) with papilledema, elevated LP opening pressure (34 cm H₂O), normal MRI, MRV showing non-dominant right transverse sinus stenosis, and progressive visual field loss despite acetazolamide and weight loss counseling. These findings define medically refractory IIH with vision threat. Main logical issue: None. The item presents a single best answer. ONSF (D) is the most vision-specific intervention. Alternative analysis: VP shunt (A) is also a standard option for refractory IIH, but the question's emphasis on progressive *visual* loss and the provided rationale correctly position ONSF as the preferred immediate step for vision protection. Transverse sinus stenting (B) is inappropriate for a non-dominant stenosis without a pressure gradient. Topiramate (C) is insufficient as a medical escalation in the face of progressive vision loss. Anticoagulation (E) is not indicated without thrombosis. Medical accuracy: The keyed answer aligns with mainstream neuro-ophthalmology practice where ONSF is favored for urgent vision protection. The rationale is slightly simplified regarding VP shunt timing but is board-appropriate. Score: 4. Minimal fix: None required; item is well-constructed and discriminates appropriately.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124-008", "question": "A 29-year-old woman with a history of two early first-trimester miscarriages and one unexplained fetal demise at 28 weeks presents for preconception counseling. She has livedo reticularis and episodes of digital ischemia in cold weather. Labs: platelets 110,000/µL, hemoglobin 11.5 g/dL, creatinine 0.9 mg/dL. Coagulation profile is normal. aPTT is mildly prolonged. Lupus anticoagulant is repeatedly positive; anticardiolipin IgG and anti-β2-glycoprotein I IgG are high-titer on two occasions 12 weeks apart. She has no personal history of venous or arterial thrombosis. Which of the following is the most appropriate pregnancy management plan?", "options": ["Low-dose aspirin alone starting preconception, escalate to prophylactic LMWH only if thrombosis occurs", "Therapeutic-dose LMWH plus low-dose aspirin starting at positive pregnancy test and continuing 6 weeks postpartum", "Prophylactic-dose LMWH plus low-dose aspirin starting at conception and stopping at delivery", "Low-dose aspirin only during pregnancy, with postpartum prophylactic LMWH for 6 weeks", "No anticoagulation unless she develops hypertensive disorders of pregnancy"], "answer": "B", "answer_index": 1, "explanation": "She meets criteria for high-risk obstetric antiphospholipid syndrome with recurrent pregnancy loss and triple-positive aPL; therapeutic-dose LMWH plus low-dose aspirin throughout pregnancy and 6 weeks postpartum provides optimal maternal and fetal protection. Aspirin alone (A, D, E) is inadequate in high-risk APS. Prophylactic-dose LMWH (C) may be used in lower-risk obstetric APS but is insufficient here given triple positivity and prior late fetal loss and thrombocytopenia suggestive of high thrombotic risk.", "generator_model": "gpt-5.1-2025-11-13", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity: V (Valid). This item presents a high-risk obstetric antiphospholipid syndrome (APS) scenario with triple antibody positivity (lupus anticoagulant, high-titer anticardiolipin and anti-β2-glycoprotein I), a prior late fetal demise at 28 weeks, thrombocytopenia (110k/µL), and microvascular manifestations (livedo reticularis, digital ischemia). These features collectively define high-risk obstetric APS, mandating therapeutic-dose LMWH plus low-dose aspirin initiated upon pregnancy detection and continued through 6 weeks postpartum. The keyed answer (B) is uniquely defensible and represents current standard of care per ACR/EULAR/ACOG guidelines. Aspirin alone (A, D, E) is insufficient for high-risk disease, while prophylactic-dose LMWH (C) is inadequate given triple positivity and late fetal loss. No internal contradictions exist; the mild thrombocytopenia does not contraindicate therapeutic anticoagulation. The item's logic is sound, options permit clear discrimination, and the key is correct. Medical accuracy is gold-standard, aligning precisely with contemporary management algorithms for high-risk obstetric APS. No revisions are necessary.\",\n\"medical_accuracy_score\": 5,\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). This item presents a high-risk obstetric antiphospholipid syndrome (APS) scenario with triple antibody positivity (lupus anticoagulant, high-titer anticardiolipin and anti-β2-glycoprotein I), a prior late fetal demise at 28 weeks, thrombocytopenia (110k/µL), and microvascular manifestations (livedo reticularis, digital ischemia). These features collectively define high-risk obstetric APS, mandating therapeutic-dose LMWH plus low-dose aspirin initiated upon pregnancy detection and continued through 6 weeks postpartum. The keyed answer (B) is uniquely defensible and represents current standard of care per ACR/EULAR/ACOG guidelines. Aspirin alone (A, D, E) is insufficient for high-risk disease, while prophylactic-dose LMWH (C) is inadequate given triple positivity and late fetal loss. No internal contradictions exist; the mild thrombocytopenia does not contraindicate therapeutic anticoagulation. The item's logic is sound, options permit clear discrimination, and the key is correct. Medical accuracy is gold-standard, aligning precisely with contemporary management algorithms for high-risk obstetric APS. No revisions are necessary.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124-009", "question": "A 55-year-old man from a region endemic for Lyme disease presents with 1 week of rapidly progressive bilateral leg weakness and numbness ascending from the feet, severe radicular pain, and new urinary retention. He was treated with oral doxycycline 3 weeks ago for erythema migrans following a hiking trip. Exam: symmetric lower extremity weakness 3/5 proximally and distally, hyperreflexia with bilateral Babinski signs, decreased pinprick below T10, preserved vibration sense in toes, and saddle hypesthesia. Cranial nerves are normal. MRI spine with contrast: multifocal enhancing lesions in the thoracic cord with associated leptomeningeal enhancement; no compressive lesion. CSF: WBC 220/µL (80% lymphocytes), protein 120 mg/dL, glucose 45 mg/dL (serum 90), oligoclonal bands present; CSF Lyme antibody index is elevated. HIV, syphilis, and TB tests are negative. What is the most appropriate treatment?", "options": ["High-dose IV methylprednisolone alone for presumed idiopathic transverse myelitis", "IV ceftriaxone 2 g daily for 4 weeks without steroids", "IV ceftriaxone 2 g daily plus high-dose IV methylprednisolone", "Oral doxycycline 100 mg BID for 28 days plus high-dose oral prednisone taper", "Plasma exchange for 5-7 sessions followed by IV ceftriaxone"], "answer": "B", "answer_index": 1, "explanation": "This is Lyme neuroborreliosis with meningomyelitis confirmed by elevated CSF Lyme antibody index and appropriate clinical picture; standard treatment is prolonged IV ceftriaxone without routine adjunctive steroids. Steroids alone (A) are inappropriate and may worsen infection. Adding high-dose steroids to antibiotics (C) has no proven benefit and may be harmful. Oral doxycycline (D) is inadequate for CNS parenchymal involvement. Plasma exchange (E) is used in severe autoimmune demyelination (e.g., NMO, ADEM) and is not indicated here once Lyme is confirmed.", "generator_model": "gpt-5.1-2025-11-13", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity: V (valid). The vignette provides a classic picture of Lyme neuroborreliosis with meningomyelitis: recent erythema migrans treated with doxycycline, now rapidly progressive bilateral leg weakness, radicular pain, urinary retention, MRI showing multifocal thoracic cord enhancement with leptomeningeal involvement, CSF pleocytosis (220 WBC, 80% lymphocytes), high protein, low glucose, oligoclonal bands, and an elevated CSF Lyme antibody index. These findings uniquely point to Lyme neuroborreliosis. The question asks for the most appropriate treatment. Option B (IV ceftriaxone 2 g daily for 4 weeks without steroids) aligns with IDSA guidelines, which recommend prolonged IV ceftriaxone for CNS Lyme disease and discourage routine steroid use because steroids may worsen infection and have no proven benefit. Options A, C, D, and E are inferior: steroids alone (A) or combined with antibiotics (C) lack evidence and may be harmful; oral doxycycline (D) is inadequate for parenchymal CNS involvement; plasma exchange (E) is reserved for autoimmune demyelination and is not indicated here. No internal contradictions or missing details prevent a single best answer. Medical accuracy is high; the scenario reflects current consensus. No revision needed.\",\n\"medical_accuracy_score\": 5,\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (valid). The vignette provides a classic picture of Lyme neuroborreliosis with meningomyelitis: recent erythema migrans treated with doxycycline, now rapidly progressive bilateral leg weakness, radicular pain, urinary retention, MRI showing multifocal thoracic cord enhancement with leptomeningeal involvement, CSF pleocytosis (220 WBC, 80% lymphocytes), high protein, low glucose, oligoclonal bands, and an elevated CSF Lyme antibody index. These findings uniquely point to Lyme neuroborreliosis. The question asks for the most appropriate treatment. Option B (IV ceftriaxone 2 g daily for 4 weeks without steroids) aligns with IDSA guidelines, which recommend prolonged IV ceftriaxone for CNS Lyme disease and discourage routine steroid use because steroids may worsen infection and have no proven benefit. Options A, C, D, and E are inferior: steroids alone (A) or combined with antibiotics (C) lack evidence and may be harmful; oral doxycycline (D) is inadequate for parenchymal CNS involvement; plasma exchange (E) is reserved for autoimmune demyelination and is not indicated here. No internal contradictions or missing details prevent a single best answer. Medical accuracy is high; the scenario reflects current consensus. No revision needed.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124-010", "question": "A 48-year-old woman with seropositive rheumatoid arthritis (RF and anti-CCP positive) on methotrexate and adalimumab presents with subacute dyspnea and nonproductive cough. She has never smoked. Vitals: HR 104, BP 118/70, RR 22, SpO2 91% RA. Exam: fine bibasilar crackles, no wheezing, active small-joint synovitis. PFTs: FVC 58% predicted, FEV1/FVC 0.86, DLCO 35% predicted. HRCT: basilar-predominant reticulation, traction bronchiectasis, and patchy subpleural honeycombing consistent with usual interstitial pneumonia (UIP); no nodules or pleural effusions. Which of the following is the most appropriate disease-modifying management change?", "options": ["Continue methotrexate and adalimumab and add low-dose prednisone", "Discontinue methotrexate and switch adalimumab to rituximab", "Stop adalimumab and start tocilizumab while continuing methotrexate", "Continue current RA regimen and initiate mycophenolate mofetil for lung disease", "Add nintedanib while continuing methotrexate and adalimumab unchanged"], "answer": "B", "answer_index": 1, "explanation": "She has RA-associated ILD with a UIP pattern, in which methotrexate and TNF inhibitors are relatively contraindicated due to concerns for ILD progression; rituximab is preferred as an RA biologic in ILD. Continuing MTX/TNF with steroids (A) risks worsening lung fibrosis. Tocilizumab (C) has less data and does not address TNF-risk concerns. Adding mycophenolate (D) without removing potential pulmonary offenders is suboptimal. Nintedanib (E) may be beneficial in progressive fibrosing RA-ILD, but first-line is to remove MTX/TNF and choose an ILD-favorable biologic such as rituximab.", "generator_model": "gpt-5.1-2025-11-13", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\": \"Validity: V. The vignette presents RA-ILD with UIP pattern in a patient on methotrexate and adalimumab. Key discriminating findings include basilar-predominant reticulation/honeycombing on HRCT and severely reduced DLCO (35%), indicating advanced fibrosis. Current rheumatology consensus uniquely supports discontinuing both methotrexate and TNF inhibitors in RA-ILD due to established risks of progression, with rituximab as the preferred alternative biologic. This makes option B the single best answer. Options A and C continue methotrexate (a known pulmonary offender), D fails to remove potential triggers, and E adds antifibrotic without addressing immunomodulatory drivers. No internal contradictions exist, and all options permit meaningful discrimination. Medical accuracy is high and aligns with ACR/EULAR guidance. A minimal fix would be specifying 'progressive' disease to clarify antifibrotic timing, but this does not alter the immediate priority of removing MTX/TNF inhibitors.\", \"medical_accuracy_score\": 4, \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. The vignette presents RA-ILD with UIP pattern in a patient on methotrexate and adalimumab. Key discriminating findings include basilar-predominant reticulation/honeycombing on HRCT and severely reduced DLCO (35%), indicating advanced fibrosis. Current rheumatology consensus uniquely supports discontinuing both methotrexate and TNF inhibitors in RA-ILD due to established risks of progression, with rituximab as the preferred alternative biologic. This makes option B the single best answer. Options A and C continue methotrexate (a known pulmonary offender), D fails to remove potential triggers, and E adds antifibrotic without addressing immunomodulatory drivers. No internal contradictions exist, and all options permit meaningful discrimination. Medical accuracy is high and aligns with ACR/EULAR guidance. A minimal fix would be specifying 'progressive' disease to clarify antifibrotic timing, but this does not alter the immediate priority of removing MTX/TNF inhibitors.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}]